Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereof
Abstract:
The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
Information query
Patent Agency Ranking
0/0